Skip to Content
 
Nishitha M. Reddy

Nishitha M. Reddy, M.B.B.S., MsCI

Associate Professor of Medicine (Hematology/Oncology)
Hematologist/Oncologist

  • Appointments
    615-936-8422
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Division of Hematology/Oncology
    (615) 322-4967

    Office
    615-936-0381
  • Faxes
    Division of Hematology/Oncology Fax
    (615) 343-7602
    Office Fax
    615-936-1812
    Clinic Fax
    615-343-7200
  • Addresses
    Clinic
    Vanderbilt University Medical Center
    1301 Medical Center Drive, Suite 3903
    Nashville, TN 37232-5505

    Division of Hematology/Oncology
    2220 Pierce Ave, 777 PRB
    Nashville, TN 37232-6307
    Website

    Office
    1301 Medical Center Drive, 3927 TVC
    Nashville, TN 37232-5505
Education
8/92-8/98, M.B.B.S., Ambedkar Medical College, Bangalore, India
Publications
  • Perales MA, Ceberio I, Armand P, Burns LJ, Chen R, Cole PD, Evens AM, Laport GG, Moskowitz CH, Popat U, Reddy NM, Shea TC, Vose JM, Schriber J, Savani BN, Carpenter PA. Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jun; 21(6): 971-83. PMID: 25773017, PII: S1083-8791(15)00152-4, DOI: 10.1016/j.bbmt.2015.02.022, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25773017.
  • Iams WT, Hames ML, Tsai JP, Dahlman KB, Talbott MS, Richards KL, Reddy NM. Increased serum tumor necrosis factor a levels in patients with lenalidomide-induced hypothyroidism. Exp. Hematol [print-electronic]. 2015 Feb; 43(2): 74-8. PMID: 25448491, PII: S0301-472X(14)00715-2, DOI: 10.1016/j.exphem.2014.10.009, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25448491.
  • Reddy NM, Perales MA. Stem cell transplantation in Hodgkin lymphoma. Hematol. Oncol. Clin. North Am [print-electronic]. 2014 Dec; 28(6): 1097-112. PMID: 25459181, PII: S0889-8588(14)00111-7, DOI: 10.1016/j.hoc.2014.08.011, ISSN: 1558-1977.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25459181.
  • Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, Olsson R, Reddy NM, Rizzieri DA, Savani BN, Solh M, Vose JM, Wirk B, Maloney DG, Smith SM, Montoto S, Saber W, Alpdogan O, Cashen A, Dandoy C, Finke R, Gale R, Gibson J, Hsu JW, Janakiraman N, Laughlin MJ, Lill M, Cairo MS, Munker R, Rowlings PA, Schouten HC, Shea TC, Stiff PJ, Waller EK. Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2014 Nov; 20(11): 1729-36. PMID: 25008330, PMCID: PMC4194275, PII: S1083-8791(14)00403-0, DOI: 10.1016/j.bbmt.2014.06.036, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25008330.
  • Iams W, Reddy NM. Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective. Ther Adv Hematol. 2014 Oct; 5(5): 153-67. PMID: 25324956, PMCID: PMC4199091, PII: 10.1177_2040620714547327, DOI: 10.1177/2040620714547327, ISSN: 2040-6207.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25324956.
  • Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu JW, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jul; 20(7): 951-9. PMID: 24641828, PMCID: PMC4060436, PII: S1083-8791(14)00163-3, DOI: 10.1016/j.bbmt.2014.03.014, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24641828.
  • Johnson DB, Dahlman KH, Knol J, Gilbert J, Puzanov I, Means-Powell J, Balko JM, Lovly CM, Murphy BA, Goff LW, Abramson VG, Crispens MA, Mayer IA, Berlin JD, Horn L, Keedy VL, Reddy NM, Arteaga CL, Sosman JA, Pao W. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist [print-electronic]. 2014 Jun; 19(6): 616-22. PMID: 24797823, PMCID: PMC4041676, PII: theoncologist.2014-0011, DOI: 10.1634/theoncologist.2014-0011, ISSN: 1549-490X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24797823.
  • Kun L, Hernandez-Ilizaliturri FJ, Reddy NM. Novel therapeutic strategies for cutaneous T-cell lymphoma in advanced stages. Semin. Hematol [print-electronic]. 2014 Jan; 51(1): 35-41. PMID: 24468314, PII: S0037-1963(13)00154-6, DOI: 10.1053/j.seminhematol.2013.11.004, ISSN: 1532-8686.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24468314.
  • Reddy NM, Evens AM. Chemotherapeutic advancements in peripheral T-cell lymphoma. Semin. Hematol [print-electronic]. 2014 Jan; 51(1): 17-24. PMID: 24468312, PII: S0037-1963(13)00156-X, DOI: 10.1053/j.seminhematol.2013.11.006, ISSN: 1532-8686.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24468312.
  • Reddy NM, Oluwole O, Greer JP, Engelhardt BG, Jagasia MH, Savani BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp. Hematol [print-electronic]. 2014 Jan; 42(1): 39-45. PMID: 24096123, PII: S0301-472X(13)00747-9, DOI: 10.1016/j.exphem.2013.09.012, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24096123.
  • Reddy NM, Savani BN. Management of T-cell lymphomas: overcoming challenges and choosing the best treatment [editorial]. Semin. Hematol [print-electronic]. 2014 Jan; 51(1): 1-4. PMID: 24468310, PII: S0037-1963(13)00159-5, DOI: 10.1053/j.seminhematol.2013.11.009, ISSN: 1532-8686.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24468310.
  • Bodiford A, Bodge M, Talbott MS, Reddy NM. Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma. Onco Targets Ther. 2014; 7: 1971-7. PMID: 25368524, PMCID: PMC4216035, PII: ott-7-1971, DOI: 10.2147/OTT.S59269, ISSN: 1178-6930.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25368524.
  • Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am. J. Clin. Pathol. 2013 Nov; 140(5): 643-50. PMID: 24124142, PMCID: PMC4159763, PII: 140/5/643, DOI: 10.1309/AJCP8CKE9NEINQFL, ISSN: 1943-7722.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24124142.
  • Stevens PL, Reddy NM. Immune surveillance and lymphoid malignancy in immunocompromised host. Am J Blood Res [electronic-print]. 2013; 3(2): 91-101. PMID: 23675561, PMCID: PMC3649811, ISSN: 2160-1992.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23675561.
  • Stover DG, Reddy VK, Shyr Y, Savani BN, Reddy N. Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma. Bone Marrow Transplant [print-electronic]. 2012 Jan; 47(1): 82-7. PMID: 21358691, PII: bmt201129, DOI: 10.1038/bmt.2011.29, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21358691.
  • Reddy N, Rezvani K, Barrett AJ, Savani BN. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol. Blood Marrow Transplant [print-electronic]. 2011 May; 17(5): 591-7. PMID: 20732435, PMCID: PMC3763478, PII: S1083-8791(10)00346-0, DOI: 10.1016/j.bbmt.2010.08.007, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20732435.
  • Reddy N, Thompson-Arildsen MA. Hodgkin's lymphoma: Richter's transformation of chronic lymphocytic leukemia involving the liver. J. Clin. Oncol [print-electronic]. 2010 Oct 10/10/2010; 28(29): e543-4. PMID: 20713878, PII: JCO.2010.29.3050, DOI: 10.1200/JCO.2010.29.3050, ISSN: 1527-7755.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20713878.
  • Reddy N, Czuczman MS. Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies. Ann. Oncol [print-electronic]. 2010 Sep; 21(9): 1756-64. PMID: 20133382, PII: mdq009, DOI: 10.1093/annonc/mdq009, ISSN: 1569-8041.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20133382.
  • Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Byrd JC, Czuczman MS, Fayad L, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kaminski MS, Kim YH, Lacasce AS, Mughal TI, Nademanee A, Porcu P, Press O, Prosnitz L, Reddy N, Smith MR, Sokol L, Swinnen L, Vose JM, Wierda WG, Yahalom J, Yunus F. NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. J Natl Compr Canc Netw. 2010 Mar; 8(3): 288-334. PMID: 20202462.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20202462.
  • Reddy N, Greer JP. Primary bone lymphoma: a set of unique problems in management. Leuk. Lymphoma. 2010 Jan; 51(1): 1-2. PMID: 20055655, DOI: 10.3109/10428190903470877, ISSN: 1029-2403.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20055655.
  • Bipin Savani and Nishitha Reddy. New Insights on Hematopoietic Cell Transplantation. [place unknown: publisher unknown]; 2010.
  • Claudio Mosse, Utpal Dave, Nishitha Reddy, Christine Lovly and John P. Greer. Molecular Pathology of Hematolymphoid Diseases. [place unknown: publisher unknown]; 2010.
  • Nishitha Reddy. Treatment for Lymphoma and Leukemias- With New Effective Therapies, is there any concern for Cardiac Issues?. 2010.
  • Olalekan Oluwole, Susan Greenhut, Bipin N Savani, and Nishitha Reddy. Surveillance in acute lymphoblastic leukemia. PATIENT SURVEILLANCE AFTER CANCER TREATMENT- An international perspective 2nd edition. 2010.
  • Savani BN, Mielke S, Reddy N, Goodman S, Jagasia M, Rezvani K. Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant [print-electronic]. 2009 Dec; 44(12): 769-77. PMID: 19855439, PII: bmt2009300, DOI: 10.1038/bmt.2009.300, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19855439.
  • Reddy N, Goodman S, Savani BN. Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-cell transplantation: is the evidence clear? [letter]. J. Clin. Oncol [print-electronic]. 2009 May 5/1/2009; 27(13): 2296-7; author reply 2297. PMID: 19307488, PII: JCO.2009.22.0897, DOI: 10.1200/JCO.2009.22.0897, ISSN: 1527-7755.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19307488.
  • Savani BN, Goodman S, Reddy N. Does extra alemtuzumab remove the graft-versus-leukemia effect after allogeneic stem cell transplantation in chronic lymphocytic leukemia? [letter]. Biol. Blood Marrow Transplant. 2009 Apr; 15(4): 517-8. PMID: 19285641, PII: S1083-8791(09)00004-4, DOI: 10.1016/j.bbmt.2008.12.511, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19285641.
  • Reddy N, Abel TW, Jagasia M, Morgan D, Weaver K, Greer J. Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab. Leuk. Lymphoma. 2009 Mar; 50(3): 460-2. PMID: 19266387, PII: 909254836, DOI: 10.1080/10428190802695827, ISSN: 1029-2403.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19266387.
  • Reddy N, Hernandez-Ilizaliturri FJ, Deeb G, Roth M, Vaughn M, Knight J, Wallace P, Czuczman MS. Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo. Br. J. Haematol [print-electronic]. 2008 Jan; 140(1): 36-45. PMID: 17995965, PII: BJH6841, DOI: 10.1111/j.1365-2141.2007.06841.x, ISSN: 1365-2141.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17995965.
  • Bipin N Savani, Nishitha Reddy, Sharon Adams and John A Barrett. Optimizing Natural Killer Activity in Allogeneic Stem Cell Transplantation. American Society of Histocompatibility and immunogenetics. 2008.
  • Reddy NM, Sullivan MA, Hahn TE, Battiwalla M, Smiley SL, McCarthy PL. Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant [print-electronic]. 2007 Nov; 40(9): 907-9. PMID: 17724441, PII: 1705833, DOI: 10.1038/sj.bmt.1705833, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17724441.
  • Reddy N, Karampelas I, Chanan-Khan A, Fenstermaker R, Padmanabhan S. Aggressive relapse of multiple myeloma with intracerebral extension and associated hemorrhage. Leuk. Lymphoma. 2007 Jun; 48(6): 1228-30. PMID: 17577791, PII: 779656423, DOI: 10.1080/10428190701272371, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17577791.
  • Reddy N, Yu J, Fakih MG. Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy. Clin Colorectal Cancer. 2007 Jan; 6(5): 362-6. PMID: 17311701, PII: S1533-0028(11)70264-X, DOI: 10.3816/CCC.2007.n.005, ISSN: 1533-0028.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17311701.
  • Reddy N, Hernandez-Ilizaliturri F, Knight J, Czuczman M. Antitumor effects of Lenalidomide in combination with IDEC114 (anti-CD80) in lymphoma bearing Severe combined Immunodeficiency (SCID) mouse model. American Society of Clinical Oncology. 2007.
  • Nishitha Reddy and Myron Czuczman. Advancements in Treating Lymphomas. Coping Magazine. 2006.
  • Hernandez-Ilizaliturri FJ, Reddy N, Holkova B, Ottman E, Czuczman MS. Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model. Clin. Cancer Res. 2005 Aug 8/15/2005; 11(16): 5984-92. PMID: 16115943, PII: 11/16/5984, DOI: 10.1158/1078-0432.CCR-05-0577, ISSN: 1078-0432.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16115943.
  • Jason Tedesco, Julianne Qualtieri, David Head, Bipin Savani and N Reddy. A high prevalence of obesity in Acute Promyelocytic Leukemia (APL) - Implications of targeted therapy to control obesity and APL prevention.
  • Nishitha Reddy and Bipin N Savani. New insights into the role of allogeneic stem cell transplantation in patients with transformed non-Hodgkins lymphoma.